Phospho-NMDAR1(Ser896)抗体特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而，抗体可通过与病毒或**的特异性结合，直接发挥中和病毒的作用。
产品编号xy- 3302R
英文名称Phospho-NMDAR1(Ser896)
中文名称磷酸化离子型谷氨酸受体1抗体
别 名NMDAR1 C1 (phospho S896); p-NMDAR1 C1 (phospho S896); NMDAR1(Phospho-Ser896); NMDAR1(Phospho-S896); NMDAR1 C1 (phospho S896); p-NMDAR1(S896); p-NMDAR1(Ser896); NMDA-NR1; N-Methyl-d-Asprtate receptor 1; GRIN1; NMDA1; NR1; Glutamate [NMDA] receptor subunit zeta 1; Glutamate receptor ionotropic N methyl D aspartate 1; Grin 1; Grin1; N methyl D aspartate receptor channel; N-methyl-D-aspartate receptor; N-methyl-D-aspartate receptor subunit NR1; NMD-R1; NMDA 1; NMDA NR1; NMDA R1; NMDA receptor 1; NMDA1; NMDAR 1; NMDAR; NR 1; NMDZ1_HUMAN.
说 明 书100ul
产品类型磷酸化抗体
研究领域细胞生物 **学 神经生物学 信号转导 转录调节因子 激酶和磷酸酶
抗体来源Rabbit
克隆类型Polyclonal
Phospho-NMDAR1(Ser896)抗体交叉反应 Human, Mouse, Rat, Chicken, Dog, Cow,
产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量103kDa
细胞定位细胞膜
性 状Lyophilized or Liquid
浓 度1mg/1ml
免 疫 原KLH conjugated Synthesised phosphopeptide derived from human NMDAR1 around the phosphorylation site of Ser896:RR(p-S)SK <Cytoplasmic>
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Phospho-NMDAR1(Ser896)抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMedPubMed
产品介绍background:
Neuronal Marker
The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
Function:
NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. This protein plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. It mediates neuronal functions in glutamate neurotransmission. Is involved in the cell surface targeting of NMDA receptors.
Subunit:
Forms heteromeric channel of a zeta subunit (GRIN1), a epsilon subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third subunit (GRIN3A or GRIN3B); disulfide-linked. Found in a complex with GRIN2A or GRIN2B, GRIN3A or GRIN3B and PPP2CB. Interacts with DLG4 and MPDZ. Interacts with LRFN1 and LRFN2. Interacts with MYZAP.
Subcellular Location:
Cell membrane; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density.
Post-translational modifications:
NMDA is probably regulated by C-terminal phosphorylation of an isoform of NR1 by PKC. Dephosphorylated on Ser-897 probably by protein phosphatase 2A (PPP2CB). Its phosphorylated state is influenced by the formation of the NMDAR-PPP2CB complex and the NMDAR channel activity.
DISEASE:
Defects in GRIN1 are the cause of mental retardation autosomal dominant type 8 (MRD8) [MIM:614254]. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.
Similarity:
Belongs to the glutamate-gated ion channel (TC 1.A.10.1) family. NR1/GRIN1 subfamily.
SWISS:
Q05586
Gene ID:
2902
Phospho-NMDAR1(Ser896)抗体（antibody,
Ab）是由效应B细胞（效应**B细胞）分泌，机体用于抵御外来物质，如病毒，**等抗原，结构呈“Y”字型的球状蛋白质，仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质，均被称作抗原，因此对于抗抗体（能够结合抗体的抗体）来说，抗体本身也是一种抗原物质。
Phospho-NMDAR1(Ser896)抗体普通抗体重链和轻链的结构
重链结构：普通的**球蛋白具有2条重链（H链），分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型，对应的**球蛋白名称分别为IgM、IgG、IgA、IgD和IgE。
轻链结构： 普通**球蛋白具有2条轻链（L链），分子质量约25kDa，有κ链和λ链两种亚型，这两种轻链决定了Ig的亚型类别（IgG1，IgG2，IgG3，IgG4）。一个天然的Ig分子两条轻链总是相同的，但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同，正常人血清**球蛋白κ链：λ链约为2：1，而在小鼠的比例为20：1。
2.2抗体Fab段和Fc段
IgG经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1个Fc段,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应；经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab’)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段（fragment of antigen binding，Fab），相当于抗体分子的两个臂，由一个完整的轻链和重链的VH和CH1结构域组成。Fc段为可结晶段（fragment crystallizable，Fc）相当于Ig的CH2和CH3结构域，是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区，以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2和CH3的区域，相当于Y字结构下面那一部分。
合格 SASH1 肿瘤抑制基因PEPE1抗体
合格 SEZ6L 癫痫样相关蛋白6抗体
合格 SIRT3 线粒体乙酰化酶3抗体
合格 TUSC1 肺癌抑癌蛋白1抗体
合格 VILIP1 神经视锥蛋白样1抗体(神经钙蛋白)
合格 WNT2 信号通路Wnt2抗体
合格 合格 Frizzled 1/Wnt receptor Wnt信号受体蛋白/Frizzled homolog 1抗体
合格 GNAT3 G蛋白转录因子α3抗体
合格 RAC1 + RAC2 G蛋白P21 RAC2抗体
合格 APBB1 interacting protein 1 β淀粉样蛋白前体结合蛋白B-1抗体
合格 RAB5 ras癌基因家族Rab5蛋白抗体
合格 RAB8A ras癌基因家族Rab8蛋白/原癌基因c MEL抗体
合格 RAB9 ras癌基因家族Rab9蛋白抗体
合格 RAB20 ras癌基因家族RAB20抗体
合格 Renin 肾素/血管紧张素形成酶Ren1抗体
合格 Thyroxine Binding Globulin 甲状腺素结合球蛋白抗体
合格 Sclerostin 骨形态发生抑制蛋白SOST抗体
合格 TROP2 细胞表面糖蛋白Trop2抗体（胰腺癌标志物蛋白）
合格 PCMT1 天门冬氨酸甲基转移酶PCMT抗体
合格 Estrogen Related Receptor beta 雌**相关受体β抗体
合格 Estrogen Related Receptor gamma 雌**受体相关蛋白3抗体
合格 RXR beta 核受体RXRβ抗体
合格 Thyroid hormone receptor alpha 甲状腺**受体α抗体
合格 BCAR1 乳腺癌抗雌**耐药蛋白1
合格 HRG beta 1 乳腺癌细胞分化因子P45抗体